These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32853186)

  • 1. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model - Tashkent, Uzbekistan, December 6, 2019-March 15, 2020.
    Dunn R; Musabaev E; Razavi H; Sadirova S; Bakieva S; Razavi-Shearer K; Brigida K; Kamili S; Averhoff F; Nasrullah M
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(34):1161-1165. PubMed ID: 32853186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Bulterys M; Ball A; Hirnschall G
    Lancet Glob Health; 2019 Sep; 7(9):e1180-e1188. PubMed ID: 31353061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Ward JW; Hinman AR
    Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP).
    Musabaev E; Estes C; Sadirova S; Bakieva S; Brigida K; Dunn R; Kottilil S; Mathur P; Abutaleb A; Razavi-Shearer K; Anstiss T; Yusupaliev B; Razavi H
    Liver Int; 2023 Apr; 43(4):773-784. PubMed ID: 36606729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.
    Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A
    Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research gaps in viral hepatitis.
    Boyd A; Duchesne L; Lacombe K
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25054. PubMed ID: 29633564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
    Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
    Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
    Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
    Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom.
    Williams J; Vickerman P; Douthwaite S; Nebbia G; Hunter L; Wong T; Ruf M; Miners A
    Value Health; 2020 Aug; 23(8):1003-1011. PubMed ID: 32828211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons Learned From Global Hepatitis C Elimination Programs.
    Handanagic S; Shadaker S; Drobeniuc J; Tsereteli M; Alkhazashvili M; Adesigbin C; Adamu I; Adabe R; Agwuocha C; Adisa O; Azania A; Boeke CE; Ngwije A; Serumondo J; Armstrong PA
    J Infect Dis; 2024 May; 229(Supplement_3):S334-S341. PubMed ID: 37739781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, detecting and enhancing the yield of previously undiagnosed hepatitis B and C in patients with acute medical admissions to hospital: a pilot project undertaken at the Vancouver General Hospital.
    Kapeluto J; Kadatz M; Wormsbecker A; Sidhu K; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):315-8. PubMed ID: 24945186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Countdown to 2030: eliminating hepatitis B disease, China.
    Liu J; Liang W; Jing W; Liu M
    Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How far are we from viral hepatitis elimination service coverage targets?
    Hutin YJ; Bulterys M; Hirnschall GO
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25050. PubMed ID: 29633520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
    Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population.
    Mazhnaya A; Geurts B; Brigida K; Bakieva S; Sadirova S; Witzigmann A; Musabaev E; Brandl M; Weishaar H; Dudareva S; Bcheraoui CE
    BMC Public Health; 2024 Jun; 24(1):1482. PubMed ID: 38831285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hepatitis B and C viral infections in Ladakh region.
    Khan MA; Zargar SA; Upadhyay J; Lone TA; Aggarwal R; Bashir G; Ali M; Rabyang S; Namgyal T; Wani ZA
    Indian J Gastroenterol; 2018 Nov; 37(6):504-510. PubMed ID: 30543047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.